These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556 [TBL] [Abstract][Full Text] [Related]
24. [How HIV and HBV ensure their survival in the cell. Cytotoxic T-cells are impaired in their function]. Knauer RH Fortschr Med; 1995 Jan; 113(3):14, 16. PubMed ID: 7890269 [No Abstract] [Full Text] [Related]
25. Persistent HIV-1-specific CTL clonal expansion despite high viral burden post in utero HIV-1 infection. Brander C; Goulder PJ; Luzuriaga K; Yang OO; Hartman KE; Jones NG; Walker BD; Kalams SA J Immunol; 1999 Apr; 162(8):4796-800. PubMed ID: 10202022 [TBL] [Abstract][Full Text] [Related]
27. [Different sensitivity of productively HIV-I infected and non-infected cells to apoptosis]. Boĭchuk SV; Ivanov AV; Mustafin Ig; Makarova MV; Dunaev PD; Aleksander L Patol Fiziol Eksp Ter; 2008; (4):7-9. PubMed ID: 19198264 [No Abstract] [Full Text] [Related]
28. Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication. Honda K; Zheng N; Murakoshi H; Hashimoto M; Sakai K; Borghan MA; Chikata T; Koyanagi M; Tamura Y; Gatanaga H; Oka S; Takiguchi M Eur J Immunol; 2011 Jan; 41(1):97-106. PubMed ID: 21182081 [TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Klenerman P; Phillips RE; Rinaldo CR; Wahl LM; Ogg G; May RM; McMichael AJ; Nowak MA Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15323-8. PubMed ID: 8986810 [TBL] [Abstract][Full Text] [Related]
30. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Rosenberg ES; Billingsley JM; Caliendo AM; Boswell SL; Sax PE; Kalams SA; Walker BD Science; 1997 Nov; 278(5342):1447-50. PubMed ID: 9367954 [TBL] [Abstract][Full Text] [Related]
31. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Ogg GS; Jin X; Bonhoeffer S; Dunbar PR; Nowak MA; Monard S; Segal JP; Cao Y; Rowland-Jones SL; Cerundolo V; Hurley A; Markowitz M; Ho DD; Nixon DF; McMichael AJ Science; 1998 Mar; 279(5359):2103-6. PubMed ID: 9516110 [TBL] [Abstract][Full Text] [Related]
32. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. Norris PJ; Moffett HF; Yang OO; Kaufmann DE; Clark MJ; Addo MM; Rosenberg ES J Virol; 2004 Aug; 78(16):8844-51. PubMed ID: 15280492 [TBL] [Abstract][Full Text] [Related]
33. New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection. Soudeyns H; Pantaleo G J Biol Regul Homeost Agents; 1997; 11(1-2):37-9. PubMed ID: 9418159 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075 [TBL] [Abstract][Full Text] [Related]
35. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. Dong T; Stewart-Jones G; Chen N; Easterbrook P; Xu X; Papagno L; Appay V; Weekes M; Conlon C; Spina C; Little S; Screaton G; van der Merwe A; Richman DD; McMichael AJ; Jones EY; Rowland-Jones SL J Exp Med; 2004 Dec; 200(12):1547-57. PubMed ID: 15596521 [TBL] [Abstract][Full Text] [Related]
36. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044 [TBL] [Abstract][Full Text] [Related]
37. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Wagner L; Yang OO; Garcia-Zepeda EA; Ge Y; Kalams SA; Walker BD; Pasternack MS; Luster AD Nature; 1998 Feb; 391(6670):908-11. PubMed ID: 9495345 [TBL] [Abstract][Full Text] [Related]
38. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. Wodarz D; Nowak MA Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307 [TBL] [Abstract][Full Text] [Related]
39. Resistance of HIV-infected cells to cytotoxic T lymphocytes. Collins KL Microbes Infect; 2004 Apr; 6(5):494-500. PubMed ID: 15109965 [TBL] [Abstract][Full Text] [Related]
40. HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure. Dekaban GA; Dikeakos JD AIDS Res Ther; 2017 Sep; 14(1):53. PubMed ID: 28893294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]